뉴스
- HLB Jumps on FDA Review Hopes...Seers Rznomics Rally[K-Bio Pulse] On June 16, South Korea’s pharmaceutical and biotechnology stocks traded largely on company-specific catalysts, including regulatory expectations, busines
- Cg MedTech Hits Limit Up...Hair Loss Stocks Rally on Insurance Coverage Hopes [K-Bio Pulse] On June 19, Shares of South Korean medical device maker Cg MedTech surged to the daily upper limit on Thursday after reports emerged that its parent company, re
- Semi Conductor Rally Dominates...But Profit Driven JLK and DT&CRO Surge on Solid Earnings[K-Bio P... As capital continued to cluster around the semiconductor sector in the domestic stock market, the bio-tech and medical technology sectors also demonstrated stea
- L&C Bio MegaCarti knee cartilage benefits hold for 4 years L&C Bio said Aug. 12 that it has secured four-year durability data for MegaCarti, its knee cartilage regeneration device, building on the early efficacy demonstrated in an earlier randomized controll...
- L&C Bio Expands ECM Platform as Tendon Tech Enters Top Journal L&C Bio announced on the 7th that its foundational research on injectable tissue reconstruction using
← 이전
3 페이지